Becker D M, Viljoen J D, Katz J, Kramer S
Br J Haematol. 1977 Jun;36(2):171-9. doi: 10.1111/j.1365-2141.1977.tb00637.x.
Erythroid ferrochelatase activity has been studied in the normoblasts of patients with porphyria variegata and protoporphyria. Two methods were used for the investigation: one using intact cells and the other lysed cells, each measuring the amount of haem synthesized by normoblasts. In patients with porphyria variegata, ferrochelatase activity estimated by both methods was approximately 50% of the normal, and in protoporphyria the ferrochelatase activity was normal in intact normoblasts but was 20% of the normal in sonicated normoblasts (marrow lysates). It is suggested therefore that in porphyria variegata a dominantly inherited structural gene mutation results in an active ferrochelatase whereas in protoporphyria the genetic mutation results in an unstable ferrochelatase. The mechanism of the enzyme instability is not known though a number of postulates are discussed.
已对混合型卟啉病和原卟啉病患者的幼红细胞中的血红素亚铁螯合酶活性进行了研究。采用了两种方法进行调查:一种使用完整细胞,另一种使用裂解细胞,每种方法均测量幼红细胞合成的血红素量。在混合型卟啉病患者中,两种方法估算的亚铁螯合酶活性约为正常水平的50%,而在原卟啉病中,完整幼红细胞中的亚铁螯合酶活性正常,但超声处理的幼红细胞(骨髓裂解物)中的亚铁螯合酶活性为正常水平的20%。因此表明,在混合型卟啉病中,显性遗传的结构基因突变导致产生有活性的亚铁螯合酶,而在原卟啉病中,基因突变导致产生不稳定的亚铁螯合酶。尽管讨论了一些假设,但酶不稳定的机制尚不清楚。